August 14, 2024 - Page 5 of 15

NASDAQ Companies - August 14, 2024

POET Technologies Reports Second Quarter 2024 Financial Results

TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the […]

NASDAQ Companies - August 14, 2024

BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2’24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET

HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — BIO-key®International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity […]

NASDAQ Companies - August 14, 2024

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) — Biofrontera Inc. (NASDAQ:BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of […]

NASDAQ Companies - August 14, 2024

Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity

BOSTON and ATLANTA, Aug. 14, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical […]

NASDAQ Companies - August 14, 2024

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

LANGHORNE, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of […]

NASDAQ Companies - August 14, 2024

Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

Monotherapy activity of long duration in patients who have progressed on checkpoint therapy via a novel immuno-oncology mechanism of action […]

NASDAQ Companies - August 14, 2024

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Presented Positive Interim ReSPECT-LM Phase 1 Data for Rhenium (186Re) Obisbemeda for Leptomeningeal MetastasesPresented Positive Topline Clinical Trial Results for […]